Latest Cost Reduction News

Wellnex Life reports a significant turnaround with a 31.5% revenue increase and near break-even operating cash flow in the December quarter, driven by strategic brand consolidation and cost discipline.

Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.

Freedom Care Group Holdings has revealed ongoing financial distress with key subsidiaries entering liquidation and persistent delays in payments from the NDIA, leaving the company with a diminished cash reserve and a strategic focus on asset sales and cost reduction.

Image Resources NL reported a strong finish to 2025 with record heavy mineral concentrate production and sales, alongside promising developments in its gold exploration and synthetic rutile innovation.

Microba Life Sciences reports a 90% year-on-year increase in core microbiome test volumes, driving a 123% rise in core testing revenue to $2.1 million, while advancing clinical adoption and cost efficiencies.

4DS Memory Limited reports steady progress in its strategic review focused on AI-related opportunities, alongside significant cost reductions and a solid cash position of $8.8 million at the end of December 2025.

Temas Resources has confirmed its patented Regenerative Chloride Leach (RCL) technology can produce commercial-grade titanium dioxide with significant cost reductions, positioning the company for global licensing opportunities.

AMP Limited has revised its cost allocation and cost-to-income ratio methodology, restating prior business unit profits and setting FY26 cost guidance between $630 million and $640 million.

Wisr Limited has reported a robust Q2FY26 with a 23% jump in its loan book and a 16% revenue increase, underpinned by a surge in loan originations and improved credit metrics. The fintech lender also strengthened its balance sheet through a capital raise and debt refinancing, setting the stage for profitability later this year.

Doctor Care Anywhere reported steady consultation growth and a third consecutive quarter of positive cashflow in Q4 2025, while advancing digital health pilots and reaffirming ambitious medium-term revenue and profitability goals.

Spenda Limited reports a 65% year-on-year jump in payment volumes and a 34% quarterly rise in cash receipts, alongside significant cost savings and leadership changes.

8common Limited reported a positive EBITDA for the first half of FY26 alongside a 4% increase in SaaS revenue, supported by significant operational cost reductions and key contract renewals.